Background and aim: Cardiac troponin I (cTnI) and natriuretic peptide NT-proBNP are useful biomarkers in the evaluation of the sick heart. We aimed to detect a potential early postoperative myocardial ...
For patients with chronic unexplained dyspnea seen in the outpatient setting, the optimal thresholds of plasma NT-proBNP currently used to diagnosis heart failure with preserved ejection fraction ...
In this new subanalysis of data from the Atherosclerosis Risk in the Communities study, investigators assessed the risk of incident heart failure (HF) or death by race and sex, as influenced by ...
The same N-terminal pro-B-type natriuretic peptides (NT-proBNP) concentration could mean drastically different absolute risks of heart failure (HF) for different demographics, according to a cohort ...
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor–Mutated Metastatic Non–Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: ...
This new study investigated the relationship between cardiac function and hemodynamics among individuals presenting with heart failure with preserved ejection fraction (HFpEF) and normal levels of ...
Baseline NT-proBNP levels in Black and White patients with wild-type ATTR-CM reflect disease severity rather than inherent ...
Diagnostic thresholds of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) for heart failure with preserved ejection fraction (HFpEF) in ambulatory patients with chronic dyspnearequire ...
Please provide your email address to receive an email when new articles are posted on . NT-proBNP may predict CV death, incident HF and fatal or nonfatal CV events after acute MI. The association was ...
BOSTON, MA—Baseline levels of NT-proBNP, as well as early changes in levels of the biomarker, provide prognostic information among patients with severe tricuspid regurgitation (TR) undergoing ...
Please provide your email address to receive an email when new articles are posted on . Cancer survivors with increased NT-proBNP levels had an elevated risk for all-cause and cardiac mortality.